Veracyte (VCYT) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate ...

We recently published 10 Shares Explode as Earnings Impress. Veracyte, Inc. (NASDAQ:VCYT) is one of the best-performing ...

Ark Invest traded in VCYT, IRDM, CRSP, KTOS, ABSI, VEEV, ADPT, and GH. Mainly focused on healthcare innovation.

Biotechnology company Veracyte (NASDAQ:VCYT) is set to replace Triumph Group (NYSE:TGI) in the S&P SmallCap 600 index prior to the market open on Tuesday, July 29. VCYT shares were +6.49% Friday ...

View the latest Veracyte Inc. (VCYT) stock price, news, historical charts, analyst ratings and financial information from WSJ.

VCYT surpassed resistance at the 20-day moving average, suggesting a short-term bullish trend. The 20-day simple moving average is a well-liked trading tool because it provides a look back at a ...

Veracyte, Inc. (NASDAQ:VCYT) generated revenue of $114.5 million in the first quarter of fiscal 2025, marking a 18% increase from last year’s comparable quarter.

Investors in Veracyte Inc (Symbol: VCYT) saw new options begin trading this week, for the February 2021 expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the VCYT ...